Abstract
In addition to inhibiting cholesterol synthesis, statins decrease the formation of isoprenoid intermediates required for the activation of RhoARho kinase pathway. Increased Rho kinase activity has been implicated in endothelial dysfunction and plays pivotal roles in cardiovascular diseases including
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
